KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) FCF Margin (2016 - 2026)

Pfizer has reported FCF Margin over the past 18 years, most recently at 93.16% for Q1 2026.

  • Quarterly FCF Margin rose 934.0% to 93.16% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 38.76% through Mar 2026, up 2774.0% year-over-year, with the annual reading at 14.5% for FY2025, 10275.0% down from the prior year.
  • FCF Margin was 93.16% for Q1 2026 at Pfizer, up from 25.65% in the prior quarter.
  • Over five years, FCF Margin peaked at 911.99% in Q3 2024 and troughed at 60.8% in Q3 2023.
  • The 5-year median for FCF Margin is 26.74% (2022), against an average of 105.05%.
  • Year-over-year, FCF Margin soared 75114bps in 2024 and then crashed -73788bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 81.5% in 2022, then skyrocketed by 50bps to 122.19% in 2023, then surged by 646bps to 911.99% in 2024, then tumbled by -97bps to 25.65% in 2025, then soared by 263bps to 93.16% in 2026.
  • Per Business Quant, the three most recent readings for PFE's FCF Margin are 93.16% (Q1 2026), 25.65% (Q4 2025), and 174.11% (Q3 2025).